Overview of Diclogesic (Diclofenac)

Property	Description
Active ingredient	Diclofenac (typically as sodium or potassium salt)
Form	Tablet, capsule, topical gel, solution for injection
Pharmacological class	Nonsteroidal Anti-Inflammatory Drug (NSAID)
Common use	Relief of pain, inflammation, and fever
Origin	Synthetic compound (Phenylacetic acid derivative)

What Type of Medicine is Diclogesic (Diclofenac)?

Diclofenac is the active ingredient in medicines like Diclogesic, classified as a potent, synthetic Nonsteroidal Anti-Inflammatory Drug (NSAID). This single product medication is chemically identified as a phenylacetic acid derivative, originating from pharmaceutical synthesis rather than a natural source. It is characterized by its action in reducing inflammatory responses, distinguishing it from general analgesics.

As an NSAID, Diclofenac differs from simple pain relievers that only target the sensation of pain. Its action is two-fold: it addresses the body's inflammatory response while simultaneously reducing pain signals. This mechanism is achieved by intervening in the biochemical process that generates specific signaling molecules, namely prostaglandins. This mechanism of blocking prostaglandin synthesis is the basis of its therapeutic utility, and it is categorized as an essential medicine for pain and palliative care.

The General Purpose and Forms of Diclofenac

The general purpose of Diclofenac is to provide relief from conditions characterized by inflammation, pain, and fever. It works by interrupting the body's inflammatory cascade, thereby reducing symptoms such as swelling, tenderness, and stiffness.

To accommodate various therapeutic needs, the compound is available in diverse dosage forms. For systemic absorption (acting throughout the body), it is supplied as tablets and capsules for oral administration, or as a solution for injection. For localized use, it is formulated into topical gels or transdermal patches, which allow for direct application to a specific area. This distinction confirms that the medicine can be used in different ways—either affecting the whole body or just a localized area—and underscores its versatility in application.

What side effects are possible with Diclogesic (Diclofenac)?

Official Safety Profile of Diclofenac

The safety profile of Diclofenac, an NSAID, is structured by government regulatory agencies based on frequency and system involvement. Adverse reactions are classified according to incidence rates observed in clinical data.

Classification	Examples of Officially Listed Adverse Reactions
Common (1 to 10 in 100 users)	Nausea, vomiting, diarrhea, abdominal pain, headache, dizziness, and elevated liver enzymes.
Rare (1 to 10 in 10,000 users)	Gastrointestinal bleeding, ulceration, gastritis, and hepatitis.

Serious adverse reactions are explicitly documented in regulatory labeling, primarily affecting major organ systems. Diclofenac is officially associated with an increased risk of Serious Cardiovascular Thrombotic Events, including myocardial infarction (heart attack) and stroke. The risk of these events may increase with the duration of use and is associated with higher doses.

Furthermore, the medicine carries a risk of Serious Gastrointestinal Adverse Events, such as bleeding, ulceration, and perforation of the stomach or intestines. Serious, though rare, skin reactions (like Stevens-Johnson syndrome) and hepatic injury have also been documented in official safety information.

Safety considerations also apply to specific populations. Regulatory texts note that older adults are at a greater risk for serious gastrointestinal adverse events. Diclofenac is generally contraindicated in specific high-risk settings, such as for the treatment of pain following Coronary Artery Bypass Graft (CABG) surgery and in individuals with established severe heart failure.

Overdose and Emergency Response

Overdose and When to Seek Help

The official regulatory profile for Diclofenac overdose focuses strictly on documented clinical manifestations, the high risk of organ toxicity, and the mandated emergency response. This information is derived from government-authorized prescribing guidelines.

Manifestations & Actions	Official Regulatory Statement
Documented Manifestations	Overdose is officially associated with prominent gastrointestinal effects, including nausea, vomiting, abdominal pain, diarrhoea, and the potential for bleeding. CNS effects such as headache, dizziness, drowsiness, and tinnitus are also documented.
Severe Outcomes	Severe, life-threatening outcomes include the risk of acute renal failure, significant hepatic damage, severe gastrointestinal perforation or bleeding, and serious neurological events such as convulsions or coma.
Antidote & Management	No specific antidote is known for Diclofenac overdose. Management must consist of immediate symptomatic and supportive treatment, which may involve gastric lavage or activated charcoal if ingestion was recent.
Population Notes	Elderly patients and individuals with documented pre-existing renal or hepatic impairment are formally noted to be at a significantly increased risk of severe, life-threatening adverse outcomes following an overdose.

Seeking Urgent Medical Help

Regulatory guidance explicitly mandates that any individual must seek immediate medical attention right away or contact emergency services immediately upon the suspicion of Diclofenac overdose. This urgent action is required due to the potential for severe, life-threatening complications which necessitate immediate hospital monitoring and specialized procedural measures, including continuous observation of vital functions and renal status.

Therapeutic Uses of Diclogesic (Diclofenac)

What Diclogesic (Diclofenac) Treats: Main Uses and Benefits

Diclogesic (Diclofenac) is commonly used in situations involving certain distressing symptoms across several therapeutic domains. Its role generally is to help provide symptomatic relief by addressing inflammation and pain.

This medication is relevant for easing symptoms related to inflammatory or irritative states in both acute and chronic contexts. It is applied across domains where additional symptomatic support may be appropriate.

The medication is commonly used across conditions presenting with acute episodes, including the severe, sudden-onset discomfort of an acute gout flare, assistance with the discomfort of an acute migraine attack, or easing the intensity of menstrual cramps. For chronic conditions, it supports the patient in managing the persistent symptoms of long-term inflammatory joint diseases like Osteoarthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis.

It is also applied in scenarios where additional management of discomfort is required, such as providing short-term symptomatic support for localized pain and swelling following soft-tissue injuries like sprains or contusions, and for post-operative pain.

“Diclofenac may assist in addressing symptom clusters that become intense or disruptive, contributing to easing the overall symptom load during periods of increased discomfort.”

This support may help patients cope more steadily with symptom fluctuations, and may assist with maintaining functional stability when symptoms interfere with routine activities.

Quick Fact: Relief for Inflammation & Pain Diclofenac is commonly used to help with symptoms related to physical discomfort and inflammatory processes, particularly when these symptoms interfere with daily functioning.

Eligibility and Restrictions for Use

Who Can and Cannot Use Diclogesic (Diclofenac)?

Eligibility for Diclofenac is strictly defined by regulatory authorities and centers on specific patient populations and existing medical conditions.

Absolute Contraindications

Diclofenac is contraindicated in several groups and conditions, meaning it must not be used:

Patients with a known hypersensitivity to the drug or any other NSAID, including those with a history of asthma, urticaria, or allergic reactions to aspirin.
Patients in the setting of Coronary Artery Bypass Graft (CABG) surgery.
Patients in the third trimester of pregnancy (at or about 30 weeks gestation and later).
Patients with active gastrointestinal ulceration, bleeding, or perforation.
Patients with established severe heart failure (NYHA II–IV) or established Ischaemic Heart Disease.

Population Restrictions and Limitations

Population Group	Regulatory Status
Pediatric Use	Many oral formulations are not recommended for children under 14 years of age. Safety is not established for children under 12 for many forms.
Geriatric Use	Use requires particular caution due to increased risk; the lowest effective dose is recommended.
Organ Function	Advanced renal disease or hepatic impairment requires avoidance or close medical surveillance, respectively.
Lactation	Not recommended, as the drug passes into human milk.

What should I know about interactions with other medicines?

This section outlines specific interactions of Diclofenac with other products, as defined by official government regulatory documents.

Contraindicated Combinations

Co-administration with other NSAIDs or COX-2 inhibitors (excluding low-dose prophylactic aspirin) is restricted due to the potential for additive risk. Use is also formally contraindicated in the setting of Coronary Artery Bypass Graft (CABG) surgery and in patients with known severe aspirin-sensitive asthma or allergies to other NSAIDs.

Pharmacodynamic and Exposure Interactions

Diclofenac co-administration presents two main interaction risks:

Increased Toxicity Risk: Combining Diclofenac with Anticoagulants, Anti-platelet Agents, SSRIs, or Oral Corticosteroids increases the documented risk of bleeding or ulceration. Similarly, co-use with Lithium or Methotrexate may raise the plasma levels and subsequent exposure of those drugs due to reduced clearance.
Impaired Efficacy: Diclofenac may cause an officially documented impaired response to certain Antihypertensive Agents (such as ACE inhibitors or ARBs), potentially leading to kidney function changes in high-risk patients. Voriconazole (a strong CYP2C9 inhibitor) is cited in regulatory sources as increasing Diclofenac's overall exposure (Cmax and AUC).

Food and Timing Constraints

Specific Diclofenac formulations, such as the oral solution or powder forms, have a mandatory regulatory requirement to be taken on an empty stomach to ensure proper absorption and effectiveness. Alcohol consumption increases the documented risk of serious Gastrointestinal problems.

Mechanism of Action

The drug Diclogesic (Diclofenac) is classified as a nonsteroidal anti-inflammatory drug (NSAID) and exerts its action by intervening directly in biochemical pathways responsible for the biosynthesis of specific lipid mediators. The core mechanism involves acting within domains of enzyme-mediated signaling, specifically through the nonselective inhibition of the cyclooxygenase (COX) enzymes, COX-1 and COX-2.

This inhibition initiates a mechanistic cascade that limits the conversion of arachidonic acid into prostanoids, including prostaglandins. Prostaglandins are key lipid mediators that regulate local inflammatory responses and physiological activity. By suppressing the synthesis of these mediators, Diclofenac modifies early molecular steps, resulting in the physiological effect of modulating activity within targeted biochemical pathways. This action contributes to an overall reduction in the concentration and effect of inflammatory mediators, influencing a downstream altered physiological response profile.

Dosage and Administration Information

Administration Guidelines for Diclofenac

Diclofenac is utilized across various forms by adhering to the principle of using the lowest effective dose for the shortest duration possible.

Administration Routes and Dosing

Diclofenac is administered via oral, topical (skin application), rectal, and parenteral (intramuscular [IM] or intravenous [IV] infusion) routes. The dosage regimen is dependent on the specific formulation and context of use:

Oral Dosing: Maintenance regimens for chronic conditions typically range from 100 mg to 150 mg per day, usually taken in divided doses (e.g., two or three times daily). The maximum daily dose is 150 mg to 200 mg, depending on the specific condition and formulation.
Parenteral Use: In acute care settings, IM or IV administration generally involves a 75 mg dose once or twice daily, with use typically restricted to a maximum of two days.
Topical Use: Gels and solutions are applied directly to the affected area, generally two to four times daily, with specific maximum daily limits for the total amount applied.

Procedural Constraints and Special Use

Administration requires adherence to specific instructions. Extended-Release (ER) and Delayed-Release (DR/EC) tablets must be swallowed whole and must not be crushed, chewed, or broken to preserve their drug release characteristics. Diclofenac oral powder, intended for rapid onset, must be mixed with water only and taken on an empty stomach.

For older adults, the general approach is to initiate treatment at the lowest effective dosage. Additionally, IV infusion solutions must be diluted and infused over a specific time period; they are not intended for rapid IV bolus injection.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Diclofenac

This section summarizes the types of clinical studies and research findings related to the evaluation of Diclofenac, based on evidence reviewed by regulatory and scientific organizations. It describes what has been studied and what remains less clear, focusing on the research context rather than clinical advice.

Evidence for Symptom Management in Osteoarthritis

Research has explored the use of both oral (taken by mouth) and topical (applied to the skin) forms of Diclofenac for use in conditions related to Osteoarthritis (OA), focusing on the knee and hand joints. These studies are often short-term Randomized Controlled Trials (RCTs). The main outcomes studied included the measurement of scores related to pain intensity, physical function (reflecting daily activities), and joint stiffness.

Studies monitored patterns observed in the trials where measurements of physical discomfort and functional imbalance were recorded over several weeks. What remains uncertain is the full profile of long-term outcomes and durability of the observed patterns when used consistently for many years. Data for groups with the most severe forms of OA remain insufficient in controlled trials.

Evidence for Chronic Inflammatory Conditions (RA and AS)

Clinical research evaluated the use of Diclofenac in conditions marked by functional limitations like Rheumatoid Arthritis (RA) and Ankylosing Spondylitis (AS), including RCTs and observational cohorts. These studies typically examined outcomes related to joint swelling, tenderness, and morning stiffness in adult patients.

The evidence base is large for studying outcomes linked to inflammatory or irritative states. However, the primary trials that provided the initial evidence for its role in symptomatic relief in these chronic conditions are older. The research was studied for managing symptom intensity or variability and does not determine effects on modifying the underlying disease progression.

Research on Acute Pain and Migraine Attacks

Research explored short-term symptom patterns using single-dose RCTs for studying episodic or acute changes such as postoperative pain and acute migraine attacks. These studies focused on measuring the Total Pain Relief achieved over a few hours and the time to perceived relief. The follow-up durations were limited, as the research primarily examines outcomes over the first 4 to 24 hours post-dose. The evidence does not provide data on the management of frequent or chronic headache patterns.

Key Studies & References Pharmacological treatment of migraine and tension-type headache (NICE Guideline)

Frequently Asked Questions (FAQ)

Common questions about Diclogesic (Diclofenac) (FAQ)

Q: Can Diclogesic cause stomach problems or heartburn?

Official safety information and regulatory documents describe that Diclofenac, the active ingredient, is officially associated with a risk of Serious Gastrointestinal Adverse Events, which includes bleeding, ulceration, and perforation. Less severe, common effects like abdominal pain and gastritis (stomach irritation) are also documented in the official adverse reaction profiles for this medicine.

Q: Can Diclogesic be taken with common over-the-counter pain relievers?

Regulatory information restricts taking Diclofenac with other nonsteroidal anti-inflammatory drugs (NSAIDs) or COX-2 inhibitors due to the potential for an increased risk of side effects. The concurrent use of Diclofenac with aspirin, even low-dose aspirin, is specifically noted as increasing the risk of serious gastrointestinal events.

Q: Is Diclogesic known to interact with blood pressure medications?

Yes, official documents describe a possible interaction. Diclofenac may cause an impaired response to certain Antihypertensive Agents (medicines used to treat high blood pressure), such as ACE inhibitors or ARBs. This interaction is noted as potentially leading to changes in kidney function in high-risk patients.

Q: What is the official guidance on using Diclogesic and alcohol?

Official warnings state that consuming alcohol while using Diclofenac increases the documented risk of serious Gastrointestinal problems. Regulatory warnings describe that this combination carries an increased risk, which often leads to guidance to limit or avoid use.

Q: What is known about Diclogesic use during lactation?

Diclofenac is officially not recommended for use while breastfeeding. The drug's presence in human milk is noted due to the potential for serious adverse reactions in nursing infants.

Q: Does Diclogesic affect liver function?

Official safety information notes that Diclofenac use is associated with a risk of elevated liver enzymes, which is a common effect. Regulatory agencies also document the potential for rare, serious adverse events like hepatic injury (liver damage). Patients with established severe hepatic impairment may require avoidance or close medical surveillance.

Q: How quickly does Diclogesic start to work after taking it?

Studies referenced in regulatory contexts show that the time it takes to reach maximum concentration in the blood (Tmax) for standard oral tablets is delayed when taken with food compared to an empty stomach. Certain specialized formulations, like oral powder, are specifically designed to be taken on an empty stomach for faster absorption.

Q: Is it common to feel dizzy or sleepy when taking Diclogesic?

Official safety profiles list dizziness as a common side effect of Diclofenac. Regulatory patient information also mentions that feeling dizzy or unsteady is possible, which is why warnings about driving or operating machinery are included.

Q: What medicines should not be taken while using Diclogesic?

Diclofenac is formally contraindicated (must not be used) with several groups of medicines, including other nonsteroidal anti-inflammatory drugs (NSAIDs), COX-2 inhibitors, and for patients recovering from Coronary Artery Bypass Graft (CABG) surgery. It is also generally avoided with certain drugs like anticoagulants and SSRIs due to an increased risk of bleeding.

Q: Why does the packaging for Diclogesic have a specific heart warning?

The official packaging warnings are based on the documented, increased risk of Serious Cardiovascular Thrombotic Events, including heart attack and stroke. Regulatory documents indicate that the risk of these events may increase with the duration of use and is associated with higher doses.

Q: Can Diclogesic be taken alongside an aspirin regimen?

Regulatory documents state that the restriction on combining Diclofenac with other NSAIDs specifically excludes low-dose prophylactic aspirin. However, official warnings note that combining Diclofenac and aspirin increases the risk of serious gastrointestinal events.

Q: Does taking Diclogesic with food change how it works?

Studies on the absorption of standard oral forms indicate that taking Diclofenac with food may delay the time it takes to reach the peak concentration in the blood and may reduce the overall concentration. Certain specific formulations have mandatory regulatory requirements to be taken on an empty stomach.

Q: Can Diclogesic affect laboratory test results?

Nonclinical studies reviewed by regulatory agencies have occasionally noted changes in certain lab parameters, such as slight changes in red blood cell counts and minor decreases in total protein and albumin in test subjects. This is not a general claim, but it indicates that some laboratory values may be affected.

Q: Are there official warnings about Diclogesic and driving or operating machinery?

Yes, regulatory patient information includes warnings about driving or operating machinery. This caution is based on the potential for side effects such as dizziness, tiredness, or visual disturbances, which could affect a person's ability to drive safely.

Q: Is it possible to overdose on Diclogesic?

Official product information for Diclofenac includes a specific section dedicated to overdosage. This section details the expected symptoms and outlines the recommended clinical treatment approaches in the event that too much of the medicine is taken.

Q: Are there specific instructions for stopping Diclogesic?

Regulatory documents and reviews indicate that patients who are on long-term Diclofenac treatment will need to have their treatment reviewed periodically. Official patient information suggests that individuals generally do not stop taking the medicine without consulting the healthcare provider who prescribed it.

Q: Is Diclogesic commonly used for dental pain?

While not all forms are officially indicated for it, clinical research studies referenced in government records have evaluated the use of injectable Diclofenac for managing or preventing post-operative dental pain. This indicates that Diclofenac has been evaluated for this purpose in certain clinical settings.

Q: What is the evidence regarding Diclogesic and headaches?

One specific oral formulation of Diclofenac is officially indicated for the acute treatment of migraine attacks with or without aura in adults. This means research supports its use for the sudden onset of migraine symptoms, but the indication does not extend to the management of chronic or general headache patterns.

Q: Can Diclogesic be used for period pain?

Yes, specific oral formulations of Diclofenac are officially indicated for the treatment of primary dysmenorrhea. This refers to the treatment of menstrual pain.

How should Diclogesic (Diclofenac) be stored and disposed of?

Storage and Disposal Requirements for Diclofenac

Storage of Diclofenac must strictly adhere to regulatory requirements to ensure product stability.

Official Storage Conditions

Temperature: Diclofenac sodium tablets must be stored at controlled room temperature, specifically between 20 C and 25 C (68 F and 77 F), with permitted excursions. Topical gels must be stored below 25 C.
Container Rules: Oral tablets must be kept in the original container and maintained tightly closed to protect the product from moisture.
Stability: Diclofenac 1% gel has an in-use stability period of 6 months after first opening the container.

Safety and Disposal

All forms of this medicine must be kept out of the sight and reach of children.

Unused or expired Diclofenac must be disposed of in accordance with local requirements. Regulatory warnings specify that topical waste, such as residue on paper towels, should not be discarded into wastewater due to environmental concerns.

Diclogesic (Diclofenac)